Oncolytics Biotech, Inc. (ONCY)

0.4978 -0.05 (-9.09%) USD  |  NASDAQ  |  Oct 16, 16:00
0.4978 0.00 (0.00%) After-Hours: 16:32
More

Oncolytics Biotech Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for ONCY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Operating Expenses (% of Quarterly Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Anixa Biosciences, Inc. --
Mera Pharmaceuticals, Inc. --